GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,598,000 | +48.5% | 1,010,270 | +136.8% | 0.00% | +50.0% |
| Q3 2016 | $9,833,000 | +78.2% | 426,591 | +28.2% | 0.00% | +100.0% |
| Q2 2016 | $5,519,000 | +108.1% | 332,665 | +99.0% | 0.00% | 0.0% |
| Q1 2016 | $2,652,000 | -52.1% | 167,182 | -2.3% | 0.00% | 0.0% |
| Q4 2015 | $5,532,000 | -20.4% | 171,121 | +3.9% | 0.00% | -50.0% |
| Q3 2015 | $6,947,000 | – | 164,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |